Capricor Therapeutics (CAPR) Shares Issued (2011 - 2024)
Capricor Therapeutics (CAPR) posted quarterly Shares Issued of $59850.0 for Q4 2024, down 99.27% year-over-year from $8.2 million in Q1 2024, and down 86.96% quarter-over-quarter from $458869.0 in Q3 2024.
Capricor Therapeutics (CAPR) Shares Issued (2011 - 2024) Analysis & Trends
Capricor Therapeutics' Shares Issued history runs 10 years deep, the most recent figure standing at $59850.0 for Q4 2024.
- In Q4 2024, Shares Issued fell 99.27% year-over-year to $59850.0; the TTM figure through Dec 2024 stood at $59850.0 (down 99.27% YoY), while the FY2024 annual figure was $59850.0, down 99.27% from the prior year.
- Shares Issued for Q4 2024 stood at $59850.0, down from $458869.0 in the prior quarter.
- The five-year high for Shares Issued was $10.6 million in Q1 2024, with the low at $59850.0 in Q4 2024.
- The 5-year median for Shares Issued is $1.9 million (2022), against an average of $2.8 million.
- Peak annual rise in Shares Issued reached 505.05% in 2024, while the deepest fall reached 99.27% in 2024.
- Capricor Therapeutics' Shares Issued stood at $2.4 million in 2020, then soared by 60.63% to $3.8 million in 2021, then soared by 52.27% to $5.8 million in 2022, then jumped by 42.51% to $8.2 million in 2023, then tumbled by 99.27% to $59850.0 in 2024.
- Business Quant data shows CAPR's Shares Issued at $59850.0 in Q4 2024, $458869.0 in Q3 2024, and $357625.0 in Q2 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 18.36 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Capricor Therapeutics | 383.47 Mn | 383.47 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 59,850.00 |
| Dec 31, 2024 | 59,850.00 |
| Sep 30, 2024 | 458,869.00 |
| Sep 30, 2024 | 458,869.00 |
| Jun 30, 2024 | 357,625.00 |
| Jun 30, 2024 | 357,625.00 |
| Mar 31, 2024 | 10.63 Mn |
| Mar 31, 2024 | 10.63 Mn |
| Dec 31, 2023 | 8.23 Mn |
| Dec 31, 2023 | 8.23 Mn |
| Sep 30, 2023 | 1.26 Mn |
| Sep 30, 2023 | 1.26 Mn |
| Jun 30, 2023 | 1.82 Mn |
| Jun 30, 2023 | 1.82 Mn |
| Mar 31, 2023 | 1.76 Mn |
| Mar 31, 2023 | 1.76 Mn |
| Dec 31, 2022 | 5.78 Mn |
| Dec 31, 2022 | 5.78 Mn |
| Sep 30, 2022 | 2.64 Mn |
| Sep 30, 2022 | 2.64 Mn |